Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.

Closing Bell

Novo Nordisk Slashes Insulin Drug Prices By 75%

And one of America's biggest sellers of insulin is following Eli Lilly's lead and lowering the cost of its life saving drug by 75%. Novo Nordisk confirms by January 2020 for it will cut the list price of its NovoLOG insulin by 75%. And the prices of Nova Allen and Lavi mere by 65%. A lot of people are not gonna see the difference in their monthly medical bills because they pay a fixed monthly copays. But for people without insurance and those with high deductibles, this is gonna be life changing.